About this Event
Session Faculty:
J. Hudson Garrett Jr., PhD, MSN, MPH, MBA, FNP, IP-BC, PLNC, CFER, AS-BC, VA-BC, MSL-BC, CPPS, CPHQ, CPXP, CVAHP, FACDONA, FAAPM, FNAP, FIDSA, FSHEA
Adjunct Assistant Professor of Medicine
Division of Infectious Diseases
University of Louisville School of Medicine
Karen Niven, MS, BSN, RN, CVAHP
Director, Performance Groups and Value Analyis
Premier, Inc.
President-Elect, Association for the Healthcare Value Analysis
Ruth Carrico, DNP, PhD, FNP-C, APRN, CIC, FSHEA, FNAP, FAAN
Executive Director
Norton Infectious Diseases Institute
Adjunct Professor
Division of Infectious Diseases
University of Louisville School of Medicine
Session Objectives:
• Discuss the clinical and patient safety implications of the recent FDA Safety Alert regarding reusable flexible endoscopes used in the gastroenterology, urology, pulmonology, and ENT specialties
• Review the current evidence-based clinical recommendations for infection control related to the use of medical devices to prevent cross-contamination and infection risk
• Discuss how to operationalize the FDA, CDC, AHVAP, and AORN recommendations to mitigate risks to the patient and improve the value of care delivery and product selection
Session Overview:
Recently, the Food and Drug Administration released a series of Safety Alerts to notify healthcare providers and facilities of recent adverse events associated with reprocessing failures and device design challenges of reusable flexible endoscopes and other medical devices. These Safety Alerts provided multiple strategies to improve patient safety, reduce cross-contamination, and move towards elimination of the riskiest components of the use of the bronchoscope. During this symposium program, our expert faculty will review evidence-based strategies to improve infection control practices and eliminate reprocessing errors commonly observed in clinical practice, improve clinical outcomes, and facilitate efficient value analysis processes.
Accreditation Statement: Community Health Associates is an approved nursing continuing education provider by the California Board of Nursing. This activity provides 1.0 Contact Hours for successful completion of this activity. You must attend the entire activity (including Q & A) in order to receive your continuing education credit.
J. Hudson Garrett Jr., PhD, MSN, MPH, MBA, FNP, IP-BC, PLNC, CFER, AS-BC, VA-BC, MSL-BC, CPPS, CPHQ, CPXP, CVAHP, FACDONA, FAAPM, FNAP, FIDSA, FSHEA
Adjunct Assistant Professor of Medicine
Division of Infectious Diseases
University of Louisville School of Medicine
Biography:
Dr. Hudson Garrett the President and Chief Executive Officer for Community Health Associates, is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine, and a Consultant Faculty member for the newly created Norton Infectious Diseases Institute which is a CDC-funded training center. He also co-founded the nonprofit the Infection Prevention Institute to help shepherd the dissemination of best practices of infection prevention and control across the healthcare continuum of care globally. He holds a Graduate Certificate in Infection Prevention and Infection Control from the University of South Florida. He has completed the Johns Hopkins Fellows Program in Hospital Epidemiology and Infection Control. He is also a Fellow in the Academy of National Associations of Directors of Nursing Administration and was selected as a Lifetime Member in the Association, which is the highest honor bestowed upon a member. He is also a Fellow, of the American Academy of Project Management, and a Senior Fellow and Ambassador of the Management and Strategy Institute. In 2019, he was inducted as a Distinguished Fellow and Practitioner in the National Academies of Practices. Dr. Garrett was recently selected in 2020 as 1 of 20 healthcare leaders globally to participate in the 2021 13-month Global Patient Safety Fellowship with the Institute for Healthcare Improvement and is a graduate of the IHI Patient Safety Executive Development Program. In August of 2021, Dr. Garrett was awarded the prestigious Fellowship Designation by the Society for Healthcare Epidemiology of America in recognition of his work in infectious diseases and infection prevention and control. In November 2021, he was awarded the Fellow Designation by the Infectious Diseases Society of America. He holds graduate certificates in healthcare leadership from both Cornell and the University of Notre Dame. He is an appointed member of the advisory committee for the Design Thinking in Healthcare Program at Rutgers University. He is a frequent international lecturer in the areas of infectious diseases, healthcare-associated infections, outbreak response and prevention, and infection prevention and control. He holds Board Certifications in Patient Safety, Healthcare Quality, Patient Experience, Vascular Access, Antibiotic Stewardship, Prehospital Emergency Medicine, Tactical Medicine, as a Designated Infection Control Officer, in Flexible Endoscope Reprocessing, Critical Care Fundamentals, Healthcare Value Analysis, and as a Director of Nursing in Post-Acute Care and Infection Prevention and Control.
Dr. Garrett served as the Lead Faculty Member for the Infection Prevention and Control Long Term Care ECHO Collaboration Program hosted thru the University of Louisville Trager Institute in collaboration with the Agency for Healthcare Research and Quality, Institute for Healthcare Improvement, and the New Mexico School of Medicine which delivers 16 weeks of infection prevention and control content to long term care facilities across the US. Dr. Garrett led the development of the first and only core infection prevention and control and antibiotic stewardship certifications and certificate of mastery programs in post-acute care settings. He has served on international and national organizational boards in the areas of environmental services, dental infection control, infection control, acute care infection control, post-acute care infection control, and vascular access. He has served on expert panels related to disinfection and sterilization with the United States Food and Drug Administration, Centers for Disease Control and Prevention, and the Environmental Protection Agency, most notably serving on the FDA’s Panel and Working Group for Flexible Endoscope Reprocessing. He is a member of the Scientific Advisory Board for the Healthcare Surfaces Institute. Dr. Garrett has lectured around the world and provided testimony to government and regulatory agencies on a variety of topics related to infectious diseases.
Karen Niven, MS, BSN, RN, CVAHP
Director, Performance Groups and Value Analyis
Premier, Inc.
President-Elect, Association for the Healthcare Value Analysis
Biography:
Karen’s primary responsibility is managing the Value Analysis Committee and the clinical process within the Performance Groups line of business. This is an ongoing value analysis process of identifying and articulating market requirements that define a product category’s attributes. As a clinical expert she uses her understanding and medical expertise to analyze current and future market technology trends while prioritizing customer needs. In addition Karen’s responsibilities also include assisting the clinical work groups for all Performance Groups as well as working with members and suppliers to identify and develop strategies to introduce new technology and improve product utilization.
Prior to joining Premier, Karen has more than 33 years of nursing experience in the PeriOperative Services area to include circulating, working in PACU and management of all areas in the PeriOperative arena. Her management duties included capital equipment acquisitions, total joint implant management, physician preference product ordering, daily oversight of the Department of Anesthesia, and responsibility for over 50 OR’s 12 Endoscopy procedure rooms and all Pre-op and Post-op departments.
She currently serves as the President-Elect for the Association for Healthcare Value Analysis Professionals.
Ruth Carrico, DNP, PhD, FNP-C, APRN, CIC, FSHEA, FNAP, FAAN
Executive Director
Norton Infectious Diseases Institute
Adjunct Professor
Division of Infectious Diseases
University of Louisville School of Medicine
Biography:
Dr. Carrico is the Executive Director of the Infectious Diseases Institute for Norton Healthcare, a large health system headquartered in Louisville, KY. She is also a Professor and Family Nurse Practitioner, gratis faculty, with the University of Louisville School Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA).
Dr. Carrico served as editor for the APIC Text of Infection Control and Epidemiology from 2005-2012. In 2008, Dr. Carrico was appointed to the National Biosurveillance Subcommittee (NBS) Advisory Committee to the Director, Centers for Disease Control and Prevention, and in 2010 became a SHEA Fellow. In 2011, Dr. Carrico was appointed by Secretary Sebelius (Health and Human Services), to the Healthcare Infection Control Practices Advisory Committee (HICPAC). In 2012, she was presented with the Carole DeMille Achievement Award by APIC, an honor for an Infection Preventionist. In 2013, Dr. Carrico began serving the National Foundation for Infectious Diseases as the Board’s Nurse Planner and in 2014 became a Robert Wood Johnson Foundation Executive Nurse Fellow alumna. Dr. Carrico served as the 2016 president of the Certification Board of Infection Control and Epidemiology, Inc. (CBIC). In 2018, Dr. Carrico assumed the position of president of the Kentucky Nurses Association and in 2020 was recognized as a Distinguished Fellow in the National Academies of Practice. In October 2021, Dr. Carrico was inducted as a Fellow in the American Academy of Nursing, the highest honor in the nursing profession.
Throughout her practice and academic career, Dr. Carrico and her team have received more than $30 million in funding from federal agencies such as the CDC, HRSA, DHS, and NIH as well as from industry partners all focused on infectious diseases, infection prevention, and immunization. Dr. Carrico continues to work with healthcare facilities across the spectrum of healthcare as well as communities, businesses, and public health to address the challenges and prevention of infectious diseases.
Event Venue & Nearby Stays
The Westin Indianapolis, 241 West Washington Street, Indianapolis, United States
USD 0.00